Stockreport

smartbax announces a €4.7 M Pre-Series A round to advance novel antibiotic compound through preclinical stage [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF Progressing a platform of small-molecule enzymatic activators that induce self-digestion of bacteria as novel mode of action against multi-drug resistant Gram-negative [Read more]